Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients☆
References (25)
The antiphospholipid syndrome: ten years on
Lancet
(1993)- et al.
Studies on phospholipids in the action of a lupus coagulation inhibitor
Pathology
(1975) - et al.
Chorea in systemic lupus and lupus-like disease: association with anti-phospholipid antibodies
Semin Arthritis Rheum
(1987) - et al.
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus
Lancet
(1990) - et al.
Warfarin and azathioprine: an important drug interaction
Am J Med
(1992) - et al.
Warfarin and azathioprine: a drug interaction does exist
Am J Med
(1993) - et al.
The 1982 revised criteria for the classification of systemic lupus erythematosus
Arthritis Rheum
(1982) - et al.
Primary antiphospholipid syndrome
J Rheumatol
(1989) A ‘primary’ antiphospholipid syndrome?
J Rheumatol
(1988)- et al.
Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder
Ann Rheum Dis
(1989)
The ‘primary’ antiphospholipid syndrome; major clinical and serological features
Medicine (Baltimore)
(1989)
The “primary antiphospholipid syndrome”: antiphospholipid antibody pattern and clinical features of a series of 23 patients
Autoimmunity
(1991)
Cited by (475)
Massive coronary thrombosis: An atypical presentation of antiphospholipid syndrome
2024, Medicina ClinicaSplenic infarction as presentation of antiphospholipid syndrome and systemic lupus erythematosus: A case report
2024, Revista Colombiana de ReumatologiaAntiphospholipid syndrome and haemorrhagic complications: A narrative review of the literature
2023, Revista Colombiana de ReumatologiaMyocardial involvement in anti-phospholipid syndrome: Beyond acute myocardial infarction
2022, Autoimmunity ReviewsCitation Excerpt :The prevalence of valve disease varies widely, mainly depending upon the detection method. By trans thoracic echocardiography, the rate is 30%, a figure that peaks up to 82% when a trans-esophageal approach is applied [10–20]. Progression to severe valvular regurgitation requiring surgery occurs in approximately 4–6% of cases.
Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management
2022, Journal of Heart and Lung TransplantationOBSTETRIC OUTCOMES IN PREGNANT WOMEN DIAGNOSED OF ANTIPHOSPHOLIPID SYNDROME
2021, Revista Medica Clinica Las Condes
- ☆
This work was supported by the Lupus UK, Jean Shanks Foundation, and Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq)-Brazil.
Copyright © 1994 Published by Excerpta Medica Inc.